1228631-45-5

Basic information

• Product Name: Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate
• Synonyms: Ethyl 1-Boc-3-fluoropiper...;1-tert-butyl 3-ethyl 3-fluoropiperidine-1,3-dicarboxylate;1-O-tert-butyl 3-O-ethyl 3-fluoropiperidine-1,3-dicarboxylate;Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate
• CAS NO: 1228631-45-5
• Molecular Formula: C13H22FNO4
• Molecular Weight: 275.3164832
• Mol File: 1228631-45-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate(1228631-45-5)
• EPA Substance Registry System: Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate(1228631-45-5)

Safety Data

• Hazardous Substances Data: 1228631-45-5(Hazardous Substances Data)

Usage

General Description

Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate is a synthetic chemical compound with the molecular formula C15H23NO4F. It is a derivative of piperidine, containing a fluorine atom and a tert-butoxycarbonyl (Boc) protecting group attached to the nitrogen atom. Ethyl 1-Boc-3-fluoropiperidine-3-carboxylate is commonly used in pharmaceutical research and development as a building block for the synthesis of various biologically active molecules. Its unique structure and properties make it valuable for the creation of potential drug candidates and medicinal chemistry studies. The compound is typically handled and stored in accordance with standard laboratory safety protocols due to its potentially harmful nature.

Upstream product

• 148672-74-6 ethyl N-(t-butyloxycarbonyl)nipecotate 
• 71962-74-8 Ethyl nipecotate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 1209781-11-2 tert-butyl 3-fluoro-3-(hydroxymethyl)piperidine-1-carboxylate 

Relevant articles and documents

PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS

The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

COGNITION ENHANCING COMPOUNDS AND COMPOSITIONS, METHODS OF MAKING, AND METHODS OF TREATING

The invention relates generally to muscarinic agonists, which are useful for stimulating muscarine, receptors and treating cognitive disorders. Included among the muscarinic agonists disclosed herein are oxadiazole derivatives compositions, and preparations thereof. Methods of synthesizing oxadiazole compounds also are provided. This disclosure also relates in part to compositions for enhancing cognitive function in subjects such as humans. The compositions comprising a muscarinic agonist or a pharma.ceutically suitable form thereof. This disclosure relates in part to methods of treating animals such as humans by administering such compositions.

COMPOUNDS AND COMPOSITIONS FOR COGNITION-ENHANCEMENT, METHODS OF MAKING, AND METHODS OF TREATING

Muscarinic agonists, which are useful for stimulating muscarinic receptors and treating cognitive disorders, are provided. Methods of synthesizing such agonists also are provided. Also provided are compositions for enhancing cognitive function in subjects such as humans, the compositions comprising a muscarinic agonist or a pharmaceutically suitable form thereof. Also provided are methods of treating animals such as humans by administering such compositions.